Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Sommerer

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 20, 2016
Reporting Quality-of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney TransplantationClaudia Sommerer, Martin Zeier
Therapeutic Drug Monitoring|September 30, 2015
Nuclear Factor of Activated T Cells-Regulated Gene Expression as Predictive Biomarker of Personal Response to Calcineurin InhibitorsClaudia Sommerer, Thomas Giese
Kidney Diseases (Basel, Switzerland)|December 7, 2016
Clinical Manifestation and Management of ADPKD in Western CountriesClaudia Sommerer, Martin Zeier
Clinical Transplantation|November 26, 2009
AEB071--a promising immunosuppressive agentClaudia Sommerer, Martin Zeier
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2007
The influence of immunosuppression on the development of BK virus nephropathy-- does it matter?Jörg Beimler, Claudia Sommerer, Martin Zeier
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2007
Rapid deterioration of renal function in a long-term allograft recipient with recurrent IgA nephritis--is it the only cause?Claudia Sommerer, Rüdiger Waldherr, Christian Morath
Transplantation Reviews (Orlando, Fla.)|November 26, 2015
Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?Oliver Witzke, Claudia Sommerer, Wolfgang Arns
Innere Medizin (Heidelberg, Germany)|January 14, 2026
[Polypharmacy and nephrotoxicity]David Czock, Kathrin Ebinger, Claudia Sommerer
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 2011
Calcineurin inhibitors and NFAT-regulated gene expressionClaudia Sommerer, Stefan Meuer, Martin Zeier, et al.
Clinical Immunology (Orlando, Fla.)|April 29, 2009
Monitoring immunosuppression with measures of NFAT decreases cancer incidenceThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 20, 2016
Reporting Quality-of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney TransplantationClaudia Sommerer, Martin Zeier
Therapeutic Drug Monitoring|September 30, 2015
Nuclear Factor of Activated T Cells-Regulated Gene Expression as Predictive Biomarker of Personal Response to Calcineurin InhibitorsClaudia Sommerer, Thomas Giese
Kidney Diseases (Basel, Switzerland)|December 7, 2016
Clinical Manifestation and Management of ADPKD in Western CountriesClaudia Sommerer, Martin Zeier
Clinical Transplantation|November 26, 2009
AEB071--a promising immunosuppressive agentClaudia Sommerer, Martin Zeier
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2007
The influence of immunosuppression on the development of BK virus nephropathy-- does it matter?Jörg Beimler, Claudia Sommerer, Martin Zeier
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2007
Rapid deterioration of renal function in a long-term allograft recipient with recurrent IgA nephritis--is it the only cause?Claudia Sommerer, Rüdiger Waldherr, Christian Morath
Transplantation Reviews (Orlando, Fla.)|November 26, 2015
Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?Oliver Witzke, Claudia Sommerer, Wolfgang Arns
Innere Medizin (Heidelberg, Germany)|January 14, 2026
[Polypharmacy and nephrotoxicity]David Czock, Kathrin Ebinger, Claudia Sommerer
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 2011
Calcineurin inhibitors and NFAT-regulated gene expressionClaudia Sommerer, Stefan Meuer, Martin Zeier, et al.
Clinical Immunology (Orlando, Fla.)|April 29, 2009
Monitoring immunosuppression with measures of NFAT decreases cancer incidenceThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Pageof 16